Lai Wang - Jun 7, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Global Head of R&D
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jun 7, 2021
Transactions value $
-$232,392
Form type
4
Date filed
6/9/2021, 04:46 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$232K -656 -100% $354.26 0 Jun 7, 2021 Direct F1, F2, F3
holding BGNE Ordinary Shares 195K Jun 7, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.646 to $354.54, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.